Venlafaxine
Sold as Efexor xr, Venlor, Odiven, Litha venlafaxine sr, Valexor sr, Efegen xr, Venlafaxine unicorn xr, Mylan venlafaxine, Accord venlafaxine xr, Venlafaxine xr adco, Letizia, Mebolex, Galinex, Cymlafax xr, Illovex xr, Odiven xr, Venlor xr, Venlafaxine cipla, Venlafaxine be-tabs mr, Venlafaxine xl austell, Faxedepor xl, Faxdepor xl, Venexor xr
1-[2-(Dimethylamino)-1-(4-methoxyphenyl)ethyl]cyclohexan-1-ol
Drag to rotate. Structure from PubChem CID 5656.
Background
Registration
- Applicants
- 13
- Registrations
- 56
- Schedule source
- Consolidated Schedules 06 July 2026
Applicants and registrations
| Applicant | Brands | Dosages | Registrations | Schedule | Leaflets |
|---|---|---|---|---|---|
| Viatris Healthcare (Pty) Ltd | Efexor xr | 75 mg, 150 mg | 320318, 320319 | S5 | None |
| Cipla Medpro (Pty) LtdCertificate held by Cipla Medpro (Pty) Ltd.3 of 17 cancelled | Venlor, Venlor xr, Venlafaxine cipla, Venlafaxine be-tabs mr | 37,5 mg, 75 mg, 150 mg, 225 mg, 300 mg | 370533, 560035, 560036, 560037, 560038, 560039, 590212, 590213.212, 590384, 590385, 590386, A400029, A400030, A400031, A400032, A400033, A400034 | S5 | PIPIL |
| Zydus Healthcare (Pty) LtdCertificate held by Zydus Healthcare SA (Pty) Ltd | Odiven, Odiven xr | 37,5, 50, 75, 150 | 410440, 410441, 410442, 540072, 540073, 540074 | S5 | PIPIL |
| Viatris South Africa (Pty) Ltd1 of 3 cancelled | Litha venlafaxine sr, Mylan venlafaxine | 75, 150 | 420254, 430097, 430098 | S5 | None |
| Acino Pharma (Pty) LtdCancelled | Litha venlafaxine sr, Valexor sr | 75, 150 | 420255, 420257, 420258 | S5 | None |
| Ranbaxy (SA) (Pty) Ltd2 of 4 cancelled | Efegen xr, Venlafaxine unicorn xr | 75, 150 | 420423, 420424, 420425, 420426 | S5 | None |
| Accord Healthcare (Pty) Ltd | Accord venlafaxine xr | 75 mg, 150 mg | 430138, 430139 | S5 | None |
| Adcock ingram limited | Venlafaxine xr adco, Cymlafax xr | 37,5, 75, 150, 225 mg | 430577, 430578, 430579, 520438, 520439 | S5 | PIPIL |
| Aurogen South Africa (Pty) LtdCancelled | Letizia, Mebolex, Galinex | 37,5 mg, 75 mg | 450650, 450651, 450652, 450653, 450654, 450655 | S5 | None |
| Pharma Dynamics (Pty) Ltd | Illovex xr | 300 mg | 530467 | S5 | None |
| Austell Pharmaceuticals (Pty) Ltd | Venlafaxine xl austell | 75 mg, 150 mg | A400491, A400493 | S5 | None |
| Trinity Pharma (Pty) Ltd | Faxedepor xl, Faxdepor xl | 75, 150 | A400492, A400494 | S5 | None |
| Pharmacare limited û woodmead | Venexor xr | 37,5 mg, 75 mg, 150 mg | A400606, A400607, A400608 | S5 | None |
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Efexor xr 75 MG EACH CAPSULE CONTAINS VENLAFAXINE 75,0 mg | 75 mg | 32031832/1.2/0318 | Registered | S5 | None |
| Efexor xr 150 MG EACH CAPSULE CONTAINS VENLAFAXINE 150,0 mg | 150 mg | 32031932/1.2/0319 | Registered | S5 | None |
| Venlor 37,5 EACH TABLET CONTAINS VENLAFAXINE HYDROCHLORIDE EQUIVALENT TO VENLAFAXINE 37,5 mg | 37,5 | 37053337/1.2/0533 | Registered | S5 | None |
| Odiven 37,5 EACH TABLET CONTAINS VENLAFAXINE 37,5 mg | 37,5 | 41044041/1.2/0440 | Registered | S5 | None |
| Odiven 50 EACH TABLET CONTAINS VENLAFAXINE 50,0 mg | 50 | 41044141/1.2/0441 | Registered | S5 | None |
| Odiven 75 EACH TABLET CONTAINS VENLAFAXINE 75,0 mg | 75 | 41044241/1.2/0442 | Registered | S5 | None |
| Litha venlafaxine sr 75 EACH CAPSULE CONTAINS: VENLAFAXINE 75,0 mg | 75 | 42025442/1.2/0254 | Cancelled | S5 | None |
| Litha venlafaxine sr 150 EACH CAPSULE CONTAINS: VENLAFAXINE 150,0 mg | 150 | 42025542/1.2/0255 | Cancelled | S5 | None |
| Valexor sr 75 EACH CAPSULE CONTAINS: VENLAFAXINE 75,0 mg | 75 | 42025742/1.2/0257 | Cancelled | S5 | None |
| Valexor sr 150 EACH CAPSULE CONTAINS: VENLAFAXINE 150,0 mg | 150 | 42025842/1.2/0258 | Cancelled | S5 | None |
| Efegen xr 75 EACH CAPSULE CONTAINS VENLAFAXINE 75,0 mg | 75 | 42042342/1.2/0423 | Registered | S5 | None |
| Efegen xr 150 EACH CAPSULE CONTAINS VENLAFAXINE 150,0 mg | 150 | 42042442/1.2/0424 | Registered | S5 | None |
| Venlafaxine unicorn xr 75 EACH CAPSULE CONTAINS VENLAFAXINE 75,0 mg | 75 | 42042542/1.2/0425 | Cancelled | S5 | None |
| Venlafaxine unicorn xr 150 EACH CAPSULE CONTAINS VENLAFAXINE 150,0 mg | 150 | 42042642/1.2/0426 | Cancelled | S5 | None |
| Mylan venlafaxine 75 EACH CAPSULE CONTAINS VENLAFAXINE 75,0 mg | 75 | 43009743/1.2/0097 | Registered | S5 | None |
| Mylan venlafaxine 150 EACH CAPSULE CONTAINS VENLAFAXINE 150,0 mg | 150 | 43009843/1.2/0098 | Registered | S5 | None |
| Accord venlafaxine 75 MG xr EACH CAPSULE CONTAINS VENLAFAXINE 75,0 mg | 75 mg | 43013843/1.2/0138 | Registered | S5 | None |
| Accord venlafaxine 150 MG xr EACH CAPSULE CONTAINS VENLAFAXINE 150,0 mg | 150 mg | 43013943/1.2/0139 | Registered | S5 | None |
| Venlafaxine xr 37,5 adco EACH CAPSULE CONTAINS :VENLAFAXINE 37,5 mg | 37,5Extended release capsules | 43057743/1.2/0577Approved 30 November 2021 | Registered | S5 | PIPIL |
| Venlafaxine xr 75 adco EACH CAPSULE CONTAINS VENLAFAXINE 75,0 mg | 75Extended release capsules | 43057843/1.2/0578Approved 30 November 2021 | Registered | S5 | PIPIL |
| Venlafaxine xr 150 adco EACH CAPSULE CONTAINS :VENLAFAXINE 150,0 mg | 150Extended release capsules | 43057943/1.2/0579Approved 30 November 2021 | Registered | S5 | PIPIL |
| Letizia 37,5 MG EACH TABLET CONTAINS :VENLAFAXINE 37,5 mg | 37,5 mg | 45065045/1.2/0650 | Cancelled | S5 | None |
| Letizia 75 MG EACH TABLET CONTAINS: VENLAFAXINE 75,0 mg | 75 mg | 45065145/1.2/0651 | Cancelled | S5 | None |
| Mebolex 37,5 MG tablets EACH TABLET CONTAINS: VENLAFAXINE 37,5 mg | 37,5 mgTablets | 45065245/1.2/0652 | Cancelled | S5 | None |
| Mebolex 75 MG tablets EACH TABLET CONTAINS :VENLAFAXINE 75,0 mg | 75 mgTablets | 45065345/1.2/0653 | Cancelled | S5 | None |
| Galinex 37,5 MG tablets EACH TABLET CONTAINS :VENLAFAXINE 37,5 mg | 37,5 mgTablets | 45065445/1.2/0654 | Cancelled | S5 | None |
| Galinex 75 MG tablets EACH TABLET CONTAINS: VENLAFAXINE 75,0 mg | 75 mgTablets | 45065545/1.2/0655 | Cancelled | S5 | None |
| Venlafaxine xr 225 adco | 225Extended release capsules | 52043852/1.2/0438Approved 30 November 2021 | Registered | S5 | PIPIL |
| Cymlafax xr 225 | 225 mgExtended release capsules. | 52043952/1.2/0439.438Approved 30 November 2021 | Registered | S5 | PIPIL |
| Illovex xr 300 MG EACH TABLET CONTAINS VENLAFAXINE 300,0 mg | 300 mg | 53046753/1.2/0467 | Registered | S5 | None |
| Odiven xr 37,5 EACH CAPSULE CONTAINS VENLAFAXINE HYDROCHLORIDE EQUIVALENT TO VENLAFAXINE 37,5 mg | 37,5Extended-release capsule | 54007254/1.2/0072Approved 10 September 2024 | Registered | S5 | PIPIL |
| Odiven xr 75 EACH CAPSULE CONTAINS VENLAFAXINE HYDROCHLORIDE EQUIVALENT TO VENLAFAXINE 75,0 mg | 75Extended-release capsule | 54007354/1.2/0073Approved 10 September 2024 | Registered | S5 | PIPIL |
| Odiven xr 150 EACH CAPSULE CONTAINS VENLAFAXINE HYDROCHLORIDE EQUIVALENT TO VENLAFAXINE 150,0 mg | 150Extended-release capsule | 54007454/1.2/0074Approved 10 September 2024 | Registered | S5 | PIPIL |
| Venlor xr 225 MG tablet EACH TABLET CONTAINS VENLAFAXINE HYDROCHLORIDE EQUIVALENT TO VENLAFAXINE 225,0 mg | 225 mgTablet | 56003556/1.2/0035 | Registrered | S5 | None |
| Venlor xr 300 MG tablet EACH TABLET CONTAINS VENLAFAXINE HYDROCHLORIDE EQUIVALENT TO VENLAFAXINE 300,0 mg | 300 mgTablet | 56003656/1.2/0036 | Registrered | S5 | None |
| Venlor xr 37,5 MG tablet EACH TABLET CONTAINS VENLAFAXINE HYDROCHLORIDE EQUIVALENT TO VENLAFAXINE 37,5 mg | 37,5 mgTablet | 56003756/1.2/0037 | Registered | S5 | None |
| Venlor xr 75 MG tablet EACH TABLET CONTAINS VENLAFAXINE HYDROCHLORIDE EQUIVALENT TO VENLAFAXINE 75,0 mg | 75 mgTablet | 56003856/1.2/0038 | Registered | S5 | None |
| Venlor xr 150 MG tablet EACH TABLET CONTAINS VENLAFAXINE HYDROCHLORIDE EQUIVALENT TO VENLAFAXINE 150,0 mg | 150 mgTablet | 56003956/1.2/0039 | Registered | S5 | None |
| Venlor xr 225 EACH CAPSULE CONTAINS: VENLAFAXINE HYDROCHLORIDE EQUIVALENT TO: VENLAFAXINE 225,0 mg | 225Extended-release capsules | 59021259/1.2/0212Approved 7 November 2024 | Registered | S5 | PIPIL |
| Venlafaxine 225 cipla EACH CAPSULE CONTAINS: VENLAFAXINE HYDROCHLORIDE EQUIVALENT TO: VENLAFAXINE 225,0 mg | 225 | 590213.21259/1.2/0213.212 | Registered | S5 | None |
| Venlafaxine 37,5 cipla EACH CAPSULE CONTAINS: VENLAFAXINE HYDROCHLORIDE EQUIVALENT TO VENLAFAXINE 37,5 mg | 37,5 | 59038459/1.2/0384 | Registered | S5 | None |
| Venlafaxine 75 cipla EACH CAPSULE CONTAINS: VENLAFAXINE HYDROCHLORIDE EQUIVALENT TO: VENLAFAXINE 75,0 mg | 75 | 59038559/1.2/0385 | Registered | S5 | None |
| Venlafaxine 150 cipla EACH CAPSULE CONTAINS: VENLAFAXINE HYDROCHLORIDE EQUIVALENT TO: VENLAFAXINE 150,0 mg | 150 | 59038659/1.2/0386 | Registered | S5 | None |
| Venlafaxine be-tabs mr 37,5 EACH CAPSULE CONTAINS VENLAFAXINE 37,5 mg | 37,5 | A400029A40/1.2/0029 | Cancelled | S5 | None |
| Venlafaxine be-tabs mr 75 EACH CAPSULE CONTAINS VENLAFAXINE 75,0 mg | 75 | A400030A40/1.2/0030 | Cancelled | S5 | None |
| Venlafaxine be-tabs mr 150 EACH CAPSULE CONTAINS VENLAFAXINE 150,0 mg | 150 | A400031A40/1.2/0031 | Cancelled | S5 | None |
| Venlor xr 37,5 EACH CAPSULE CONTAINS VENLAFAXINE 37,5 mg | 37,5Extended-release capsules. | A400032A40/1.2/0032Approved 7 November 2024 | Registered | S5 | PIPIL |
| Venlor xr 75 EACH CAPSULE CONTAINS VENLAFAXINE 75,0 mg | 75Extended-release capsules | A400033A40/1.2/0033Approved 7 November 2024 | Registered | S5 | PIPIL |
| Venlor xr 150 EACH CAPSULE CONTAINS VENLAFAXINE 150,0 mg | 150Extended-release capsules | A400034A40/1.2/0034Approved 7 November 2024 | Registered | S5 | PIPIL |
| Venlafaxine 150 MG xl austell EACH CAPSULE CONTAINS VENLAFAXINE 150,0 mg | 150 mg | A400491A40/1.2/0491 | Registered | S5 | None |
| Faxedepor xl 150 EACH Capsule contains: Venlafaxine hydrochloride equivalent to venlafaxine 150,0 mg | 150 | A400492A40/1.2/0492 | Registered | S5 | None |
| Venlafaxine 75 MG xl austell EACH CAPSULE CONTAINS VENLAFAXINE 75,0 mg | 75 mg | A400493A40/1.2/0493 | Registered | S5 | None |
| Faxdepor xl 75 EACH Capsule contains: Venlafaxine Hydrochloride equivalent to venlafaxine 75,0 mg | 75 | A400494A40/1.2/0494 | Registered | S5 | None |
| Venexor xr 37,5 MG EACH CAPSULE CONTAINS VENLAFAXINE 37,5 mg | 37,5 mg | A400606A40/1.2/0606 | Registered | S5 | None |
| Venexor xr 75 MG EACH CAPSULE CONTAINS VENLAFAXINE 75,0 mg | 75 mg | A400607A40/1.2/0607 | Registered | S5 | None |
| Venexor xr 150 MG EACH CAPSULE CONTAINS VENLAFAXINE 150,0 mg | 150 mg | A400608A40/1.2/0608 | Registered | S5 | None |
Regulatory status
Where S5 sits on the scale
Prescription-only, with tighter controls on repeats.
Schedule 5 medicines need a prescription, and repeat dispensing is capped at six months in total; the prescriber must state upfront how many times, and at what intervals, it may be repeated. Extra limits apply to some uses: if it is being used for its anxiolytic, antidepressant, tranquillising or analgesic properties, it cannot be prescribed for longer than six months without a further consultation. Its price, name, pack size and strength can still be told to the public, as long as nothing links it to what it treats.
Schedule S5, matched to the Consolidated Schedules by ingredient, confidence high.
Who may supply: A pharmacist dispensing against a written or verbal prescription from an authorised prescriber; a veterinarian, who may also prescribe, compound or dispense it directly; a medical practitioner or dentist, who may prescribe it and may compound or dispense it directly only if licensed under section 22C(1)(a); manufacturers and wholesalers may supply people who may lawfully possess it.
Consolidated Schedules listings for Venlafaxine
S5: Venlafaxine
Consolidated Schedules 06 July 2026, line 9761
Pharmacological class: Psychoanaleptics (antidepressants). (class 1.2)
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
SAHPRA documents
These documents are provided by SAHPRA for informational purposes. Always consult with a healthcare professional for medical advice.